Senate panel backs Biden’s FDA selection Robert CaliffRobert Califf has cleared another stage on his return journey to the top job at the FDA, after Share XSenate panel backs Biden’s FDA selection Robert Califfhttps://pharmaphorum.com/news/senate-panel-backs-bidens-fda-commissioner-selection-califf/
Califf breezes through Senate nomination hearingRobert Califf looks set to take a second term as FDA commissioner after navigating a relatively placid two-hour Share XCaliff breezes through Senate nomination hearinghttps://pharmaphorum.com/news/califf-breezes-through-senate-nomination-hearing/
Biden confirms Califf choice as FDA commissionerPresident Joe Biden ended months of speculation by formally nominating Robert Califf as the new commissioner of the Share XBiden confirms Califf choice as FDA commissionerhttps://pharmaphorum.com/news/biden-confirms-califf-choice-as-fda-commissioner/
Califf re-joining FDA would be positive for industry; analystWith rumours growing that that ex-FDA head Robert Califf looks set to receive President Joe Biden’s nomination to Share XCaliff re-joining FDA would be positive for industry; analysthttps://pharmaphorum.com/news/califf-re-joining-fda-would-be-positive-for-industry-analyst/
FDA’s Califf embraces 21st Century Cures – but questions remainYesterday the outgoing President of the United States Barack Obama signed into law the 21st Century Cures Act, Share XFDA’s Califf embraces 21st Century Cures – but questions remainhttps://pharmaphorum.com/views-and-analysis/fdas-califf-embraces-21st-century-cures-questions-remain/
